Home - Sitemap
  • About us
    • About Algeta
    • Corporate Strategy
    • Management
    • Board of Directors
    • Code of Ethics
  • Products
    • Pipeline
    • Alpharadin
    • TH-1
  • Clinical trials
    • ALSYMPCA
    • BC1-09 Breast
    • BC1-10 Combo
  • R & D
    • Technology Overview
    • Alpha-Pharmaceuticals
  • News & Media
    • Press releases
    • Events
    • Publications PDF
    • Pictures & logo
    • Media contact
    • Subscription
  • Investors
    • Share Price Information
    • Reports & Presentations
    • Webcast
    • Main Shareholders
    • Oslo Stock Exchange
    • OSE Announcements
    • Analyst Coverage
    • Financial Calendar
    • Corporate Governance
    • Board of Directors
    • Management
    • Subscription
    • IR contacts
  • Partners
    • Overview
  • Contact
    • Contact details
    • Directions
    • Careers

Pictures and logo

    • Press releases »
    • Events »
    • Publications PDF »
    • Pictures & logo »
    • Media contact »
    • Subscription »
Name Download
President and Chief Executive Officer, Andrew Kay
EVP and Chief Technology Officer, Thomas Ramdahl
Chief Medical Officer (CMO), Gillies O Bryan-Tear
VP Operations, Kari Grønås Dyvik
VP, Quality and Regulatory Affairs, Ragnhild M. Løberg
Chief Business Officer, Roger Harrison
Chief Financial Officer, Øystein Soug
Logo small
Logo medium
Logo large
Apharadin vial

Algeta ASA - PO Box 54 Kjelsås - NO-0411 Oslo - Norway - Phone: +47 23 00 79 90 - Telefax: +47 23 00 79 91

How to find us | Disclaimer